In Women, Fertility Treatment Does Not Lead to Cardiovascular Disease

A new study has found that women who gave birth following fertility treatment had no long-term increased risk of death or major cardiovascular events compared to women who gave birth without fertility therapy.

A new study has found that women who gave birth following fertility treatment had no long-term increased risk of death or major cardiovascular events compared to women who gave birth without fertility therapy.

The findings, by the Institute for Clinical Evaluative Sciences (ICES) and Women's College Hospital, are the first to show fertility medications, which can cause short-term pregnancy complications, are not associated with an increased risk of cardiovascular disease later in life.

Updated Guide to Help Policy Makers Combat Cardiovascular Disease
The American Heart Association has released new recommendations for policy makers and public health providers to combat heart disease and stroke on a local level.

"The speculated association between fertility therapy and subsequent cardiovascular disease is not surprising given that more women are waiting until an older age to have children, when they are at greater risk of developing heart disease," Dr. Jacob Udell, lead author of the study and cardiologist at Women's College Hospital, said.

Fertility therapy is used in nearly one percent of all successful pregnancies in North America.

But these medications are known to cause short-term complications such as gestational diabetes and hypertension.

Air and Noise Pollution Up Cardiovascular Disease Risk
Air pollution and noise pollution may boost a person's risk of developing heart disease, say German researchers.

These short-term risks, however, do not translate into lasting cardiovascular damage, according to the researchers.

In the study, researchers assessed the long-term risk of stroke, heart attack and heart failure following fertility therapy among 1.1 million women after delivery over a 17-year follow-up period in Ontario.

Uterus Removal Does Not Increase a Woman's Risk of Cardiovascular Disease
New research reveals having a hysterectomy with or without ovary removal in mid-life does not increase a woman's risk of cardiovascular disease compared to women who reach natural menopause.

They found a five-fold increase in the use of fertility therapy from 1993 to 2010, particularly among older women.

The use of fertility therapy was associated with an increase in pregnancy complications including a near 30 per cent increase of diabetes in pregnancy, 16 percent increase in placental disorders and a 10 percent increase in pre-eclampsia.

Walnuts Cut Cardiovascular Disease Risk
Whole walnuts or their extracted oil can cut the risk of cardiovascular disease, claim researchers.

Women who delivered following fertility therapy had about half the risk of subsequent death compared to women who did not have fertility therapy.

Women who delivered following fertility therapy had nearly half the risk of major cardiovascular events such as stroke, heart attack and heart failure.

The researchers do not believe that this is a direct effect of treatment; rather that women undergoing fertility therapy maintain a healthy lifestyle over a long period.

Researchers reported no increase in the risk of future breast or ovarian cancer in women who gave birth following fertility therapy.

Women who had fertility therapy also experienced fewer mental health events, including one-third the rate of depression and one-sixth the rate of self-harm.

The study is published in the Journal of the American College of Cardiology.

Source-ANI